iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Aurobindo Pharma’s Andhra plant gets 1 observation from USFDA following inspection

21 Sep 2023 , 09:20 AM

Aurobindo Pharma said on Wednesday that the US Food and Drug Administration issued a Form 483 with one observation after evaluating its formulation production facility in Andhra Pradesh.

The US Food and Drug Administration (US FDA) inspected APL Healthcare Ltd, a wholly-owned subsidiary of the pharma company, in the Tirupati district of Andhra Pradesh from September 13 to 19, 2023, according to a regulatory filing by the Hyderabad-based drug major.

It was mentioned that at the end of the inspection, a Form 483 was given with one procedural observation.

According to the USFDA, after the completion of an inspection, a Form 483 is sent to the firm’s management if the investigator observes any conditions that may constitute violations of the Food, Drug, and Cosmetic (FD&C) Act and other related Acts.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Aurobindo Pharma
  • Aurobindo Pharma News
  • Aurobindo Pharma Observation
  • Aurobindo Pharma Updates
  • Aurobindo Pharma USFDA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

SBI Card Q4 Profit Slips 20%
25 Apr 2025|11:17 PM
HUL Q4 Net Profit Rises to ₹2,493 Crore
25 Apr 2025|10:59 PM
Sensex and Nifty in Red on April 25, 2025
25 Apr 2025|02:08 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.